Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01060800 · ClinicalTrials.gov registry record
The Genetics of Chiari Type I Malformation
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 2,000
- Enrollment target
NCT01060800: Completed study, sponsored by Duke University.
NCT01060800 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 2,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01060800 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
Duke University Medical Center is investigating the hereditary basis of Chiari type I malformations with or without syringomyelia (CM1/S). Our research is aimed at learning if CM1/S is indeed caused by factors inherited through the family and, if so, which genes are involved.
Primary Outcome
This study aims to identify genetic factors that contribute to or cause Chiari Type I malformation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2009-06 |
| Est. Completion | 2017-04-25 |
What the finished NCT01060800 record still lists
NCT01060800 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01060800 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01060800 about?
NCT01060800 is a clinical study titled "The Genetics of Chiari Type I Malformation". Duke University Medical Center is investigating the hereditary basis of Chiari type I malformations with or without syringomyelia (CM1/S). Our research is aimed at learning if CM1/S is indeed caused by factors inherited through the family and, if so, which genes are involved.
What is the current status of trial NCT01060800?
This trial is currently completed. The enrollment target is 2,000 participants. The study started on 2009-06. Estimated completion is 2017-04-25.
Who is sponsoring clinical trial NCT01060800?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia